Invesco Biotechnology & Genome ETF (NY:PBE)

83.34 +1.49 (+1.82%)

Streaming Delayed Price Updated: 1:58 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Volume	16,900
Open	82.40
Bid (Size)	83.38 (100)
Ask (Size)	83.52 (100)
Prev. Close	81.85
Today's Range	82.40 - 83.34
52wk Range	54.52 - 85.73
Shares Outstanding	34,500
Dividend Yield	2.02%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗

January 26, 2026

The U.S. FDA approved an update to the prescribing information for Afrezza inhalation powder to treat adults with diabetes mellitus.

Via Stocktwits

MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗

November 05, 2025

Via Stocktwits

Performance

YTD	+1.2%	+1.2%
1 Month	-0.9%	-0.9%
3 Month	+9.2%	+9.2%
6 Month	+28.3%	+28.3%
1 Year	+18.5%	+18.5%

More News

Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗

October 29, 2025

Via Stocktwits

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

Via Benzinga

Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗

September 23, 2025

Via Stocktwits

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗

February 19, 2024

Via InvestorPlace

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗

April 13, 2023

Via Benzinga

Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗

April 13, 2023

Via Benzinga

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗

April 12, 2023

Via Benzinga

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗

April 11, 2023

Via Benzinga

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗

April 06, 2023

Via Benzinga

US Judge Weighs Nationwide Ban On Abortion Pills ↗

March 16, 2023

Via Benzinga

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗

March 01, 2023

Via Benzinga

7 Best Biotech Stocks to Buy in July 2022 ↗

July 08, 2022

Via InvestorPlace

Biotech ETFs That Outperformed Last Week ↗

December 20, 2021

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Via Benzinga

3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More ↗

May 30, 2021

Via Talk Markets

Frequently Asked Questions

Is Invesco Biotechnology & Genome ETF publicly traded?

Yes, Invesco Biotechnology & Genome ETF is publicly traded.

What exchange does Invesco Biotechnology & Genome ETF trade on?

Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange

What is the ticker symbol for Invesco Biotechnology & Genome ETF?

The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange

What is the current price of Invesco Biotechnology & Genome ETF?

The current price of Invesco Biotechnology & Genome ETF is 83.34

When was Invesco Biotechnology & Genome ETF last traded?

The last trade of Invesco Biotechnology & Genome ETF was at 02/06/26 01:58 PM ET

What is the market capitalization of Invesco Biotechnology & Genome ETF?

The market capitalization of Invesco Biotechnology & Genome ETF is 2.88M

How many shares of Invesco Biotechnology & Genome ETF are outstanding?

Invesco Biotechnology & Genome ETF has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.